A clinician on TikTok says a few patients lost so much weight before surgery that their knee pain eased and they skipped the operation. No drug is named.
Recap by typeshit. Video by TikTok on TikTok.
Kalkine Media ties the attention on Lilly to orforglipron's progress, arguing a pill could scale cheaper than injectables and ease supply limits.
Smaller portions could become more common on shelves, with inflation and GLP-1 appetite changes both pushing food makers toward personal packs.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
Oral Wegovy brought in about $850 million in H1 2026 and holds over 80% of new US oral scripts. Lilly says Foundayo volume doubled in a month.
University of California researchers report treated mice had better muscle and cognitive function and fewer signs of aging. Human results are still far off.
Polskie Radio covers US regulators clearing the first daily oral version of Wegovy for weight loss. Details beyond that are thin.
Loading…